- Home
- PMVP vs JMM Comparison
PMVP vs JMM Comparison
Compare PMVP & JMM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PMVP
- JMM
- Stock Information
- Founded
- PMVP 2013
- JMM 1988
- Country
- PMVP United States
- JMM United States
- Employees
- PMVP N/A
- JMM N/A
- Industry
- PMVP Medicinal Chemicals and Botanical Products
- JMM Trusts Except Educational Religious and Charitable
- Sector
- PMVP Health Care
- JMM Finance
- Exchange
- PMVP Nasdaq
- JMM Nasdaq
- Market Cap
- PMVP 55.1M
- JMM 58.6M
- IPO Year
- PMVP 2020
- JMM N/A
- Fundamental
- Price
- PMVP $1.31
- JMM $6.23
- Analyst Decision
- PMVP Strong Buy
- JMM
- Analyst Count
- PMVP 1
- JMM 0
- Target Price
- PMVP $5.00
- JMM N/A
- AVG Volume (30 Days)
- PMVP 265.0K
- JMM 16.1K
- Earning Date
- PMVP 08-07-2025
- JMM 01-01-0001
- Dividend Yield
- PMVP N/A
- JMM 5.44%
- EPS Growth
- PMVP N/A
- JMM N/A
- EPS
- PMVP N/A
- JMM N/A
- Revenue
- PMVP N/A
- JMM N/A
- Revenue This Year
- PMVP N/A
- JMM N/A
- Revenue Next Year
- PMVP N/A
- JMM N/A
- P/E Ratio
- PMVP N/A
- JMM N/A
- Revenue Growth
- PMVP N/A
- JMM N/A
- 52 Week Low
- PMVP $0.81
- JMM $5.29
- 52 Week High
- PMVP $1.82
- JMM $6.10
- Technical
- Relative Strength Index (RSI)
- PMVP 68.35
- JMM 50.20
- Support Level
- PMVP $0.96
- JMM $6.22
- Resistance Level
- PMVP $1.36
- JMM $6.41
- Average True Range (ATR)
- PMVP 0.09
- JMM 0.10
- MACD
- PMVP 0.02
- JMM -0.00
- Stochastic Oscillator
- PMVP 79.80
- JMM 42.55
About PMVP PMV Pharmaceuticals Inc.
PMV Pharmaceuticals Inc is a precision oncology company. The company is engaged in the research and development of small molecule, tumor-agnostic therapies targeting p53 mutations, which can eliminate cancer cells. Its pipeline rezatapopt PYNNACLE, rezatapopt and azacitidine, rezatapopt (PC14586), and PMV-586-101.
About JMM Nuveen Multi-Market Income Fund (MA)
Nuveen Multi-Market Income Fund is a United States-based closed-end management investment company. The investment objective of the company is to provide high monthly income consistent with prudent risk to capital. The fund predominantly invests in debt securities including, but not limited to residential and commercial mortgage-backed securities, asset-backed securities, corporate debt obligations, convertible debt securities, U.S. government securities, and other such fixed income instruments. It may also invest in preferred stocks.